Abstract
The failure of endothelin antagonists to show benefit in heart failure cannot be understood until all the clinical trials are fully published.
MeSH terms
-
Antihypertensive Agents / therapeutic use*
-
Clinical Trials as Topic*
-
Endothelin A Receptor Antagonists*
-
Endothelin-1 / physiology
-
Evidence-Based Medicine
-
Heart Failure / drug therapy*
-
Humans
-
Publishing
Substances
-
Antihypertensive Agents
-
Endothelin A Receptor Antagonists
-
Endothelin-1